Comparison Chart Cantargia AB

Equities

Market Closed - Nasdaq Stockholm Other stock markets 08:59:55 17/05/2024 pm IST			5-day change	1st Jan Change
3.6 ^SEK	-1.53%		+0.78%	-3.69%

17/04	Cantargia Publishes New Data on the Can10 Antibody, Detailing Its Interaction with IL1RAP and Functional Inhibition	CI
10/04	Cantargia AB Publishes Preclinical Data on the Potential of CAN10 in Systemic Sclerosis in A Leading Scientific Journal	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

		Sector	Change	5d. change	1st Jan change	1-year change	5-years change	Capi.	ST	MT	LT
	CANTARGIA AB	Bio Therapeutic Drugs	-1.53%	+0.78%	-3.69%	-25.06%	-80.71%	6.28Cr